Korea Meditech made technical licensing for spasmolytics.

President Kim Sang-il of Korea Meditech made a technical license agreement with Nikken Kakaku of Japan for the introduction of outstanding spasmolytic drug with less adverse reactions.

Now, Meditech could increase their revenues in such a market where an original branded drug be utmost necessary exclusively to promote under the technical license arrangement with President Shimano and Vice P...